347 related articles for article (PubMed ID: 35876420)
1. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study.
Binnenmars SH; Hoogslag GE; Yeung SMH; Brouwers FP; Bakker SJL; van Gilst WH; Gansevoort RT; Navis G; Voors AA; de Borst MH
J Am Heart Assoc; 2022 Aug; 11(15):e024952. PubMed ID: 35876420
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease.
Bansal N; Zelnick LR; Scherzer R; Estrella M; Shlipak MG
Circ Heart Fail; 2024 May; 17(5):e011173. PubMed ID: 38742428
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Leidner AS; Cai X; Zelnick LR; Lee J; Bansal N; Pasch A; Kansal M; Chen J; Anderson AH; Sondheimer JH; Lash JP; Townsend RR; Go AS; Feldman HI; Shah SJ; Wolf M; Isakova T; Mehta RC;
Kidney Med; 2023 Nov; 5(11):100723. PubMed ID: 37915961
[TBL] [Abstract][Full Text] [Related]
4. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population.
Chia YC; Kieneker LM; van Hassel G; Binnenmars SH; Nolte IM; van Zanden JJ; van der Meer P; Navis G; Voors AA; Bakker SJL; De Borst MH; Eisenga MF
J Am Heart Assoc; 2021 Jun; 10(11):e018549. PubMed ID: 33998283
[TBL] [Abstract][Full Text] [Related]
6. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
[TBL] [Abstract][Full Text] [Related]
7. Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction.
Schuermans A; Honigberg MC; Raffield LM; Yu B; Roberts MB; Kooperberg C; Desai P; Carson AP; Shah AM; Ballantyne CM; Bick AG; Natarajan P; Manson JE; Whitsel EA; Eaton CB; Reiner AP
JAMA Netw Open; 2024 Jan; 7(1):e2353244. PubMed ID: 38270950
[TBL] [Abstract][Full Text] [Related]
8. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
[TBL] [Abstract][Full Text] [Related]
9. Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.
de Boer RA; Nayor M; deFilippi CR; Enserro D; Bhambhani V; Kizer JR; Blaha MJ; Brouwers FP; Cushman M; Lima JAC; Bahrami H; van der Harst P; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Shah SJ; Levy D; Herrington DM; Larson MG; van Gilst WH; Gottdiener JS; Bertoni AG; Ho JE
JAMA Cardiol; 2018 Mar; 3(3):215-224. PubMed ID: 29322198
[TBL] [Abstract][Full Text] [Related]
10. Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults.
Zhao L; Zierath R; John JE; Claggett BL; Hall ME; Clark D; Butler KR; Correa A; Shah AM
JAMA Netw Open; 2022 Sep; 5(9):e2231878. PubMed ID: 36107422
[TBL] [Abstract][Full Text] [Related]
11. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.
Ho JE; Lyass A; Lee DS; Vasan RS; Kannel WB; Larson MG; Levy D
Circ Heart Fail; 2013 Mar; 6(2):279-86. PubMed ID: 23271790
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis.
Teramoto K; Santos M; Claggett B; John JE; Solomon SD; Kitzman D; Folsom AR; Cushman M; Matsushita K; Skali H; Shah AM
PLoS Med; 2020 Oct; 17(10):e1003361. PubMed ID: 33057391
[TBL] [Abstract][Full Text] [Related]
13. Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life.
Vu K; Claggett BL; John JE; Skali H; Solomon SD; Mosley TH; Williams JE; Kucharska-Newton A; Biering-Sørensen T; Shah AM
J Am Heart Assoc; 2021 Dec; 10(23):e020094. PubMed ID: 34796739
[TBL] [Abstract][Full Text] [Related]
14. Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure: The ARIC Study.
Molinsky RL; Yuzefpolskaya M; Norby FL; Yu B; Shah AM; Pankow JS; Ndumele CE; Lutsey PL; Papapanou PN; Beck JD; Colombo PC; Demmer RT
JACC Heart Fail; 2022 Oct; 10(10):731-741. PubMed ID: 36175058
[TBL] [Abstract][Full Text] [Related]
15. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
[TBL] [Abstract][Full Text] [Related]
16. The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.
Nayor M; Larson MG; Wang N; Santhanakrishnan R; Lee DS; Tsao CW; Cheng S; Benjamin EJ; Vasan RS; Levy D; Fox CS; Ho JE
Eur J Heart Fail; 2017 May; 19(5):615-623. PubMed ID: 28217978
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
Ferraro RA; Ogunmoroti O; Zhao D; Ndumele CE; Rao V; Pandey A; Larson NB; Bielinski SJ; Michos ED
J Card Fail; 2021 Sep; 27(9):981-990. PubMed ID: 34051347
[TBL] [Abstract][Full Text] [Related]
18. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction.
Tsao CW; Lyass A; Enserro D; Larson MG; Ho JE; Kizer JR; Gottdiener JS; Psaty BM; Vasan RS
JACC Heart Fail; 2018 Aug; 6(8):678-685. PubMed ID: 30007560
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
Nicoli CD; O'Neal WT; Levitan EB; Singleton MJ; Judd SE; Howard G; Safford MM; Soliman EZ
Heart; 2022 Mar; 108(5):353-359. PubMed ID: 34031160
[TBL] [Abstract][Full Text] [Related]
20. Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.
Pandey A; Omar W; Ayers C; LaMonte M; Klein L; Allen NB; Kuller LH; Greenland P; Eaton CB; Gottdiener JS; Lloyd-Jones DM; Berry JD
Circulation; 2018 Apr; 137(17):1814-1823. PubMed ID: 29352072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
